Mayne Pharma | MYX

Stock Price
5.28
Daily Change
0.01 0.19%
Monthly
4.14%
Yearly
17.33%
Q3 Forecast
5.25

Peers Price Chg Day Year Date
Avita Medical 1.34 0.01 0.75% -48.46% Sep/05
Ansell 34.57 0.09 0.26% 15.08% Sep/05
Cochlear 298.53 -0.25 -0.08% 3.39% Sep/05
CSL 209.25 -1.60 -0.76% -31.17% Sep/05
Healius 0.83 -0.03 -2.94% -50.00% Sep/05
Integral Diagnostics 2.90 0.05 1.75% 11.54% Sep/05
Medical Developments International 0.58 -0.01 -0.86% 36.90% Sep/05
Nanosonics 4.02 -0.06 -1.47% 12.92% Sep/05
Next Science 0.15 0 0% -27.50% Sep/05
Polynovo 1.53 0.12 8.16% -34.55% Sep/05
Ramsay Health Care 33.66 -0.45 -1.32% -15.51% Sep/05
ResMed 42.26 0.79 1.91% 15.56% Sep/05
Sonic Healthcare 22.94 -0.07 -0.30% -15.63% Sep/05
Sigma Healthcare 3.04 0.01 0.33% 139.37% Sep/05
Telix Pharmaceuticals 13.80 0.03 0.22% -22.21% Sep/05

Indexes Price Day Year Date
Australia All Ordinaries 9140 49.14 0.54% 11.27% Sep/05

Mayne Pharma traded at 5.28 this Friday September 5th, increasing 0.01 or 0.19 percent since the previous trading session. Looking back, over the last four weeks, Mayne Pharma gained 4.14 percent. Over the last 12 months, its price rose by 17.33 percent. Looking ahead, we forecast Mayne Pharma to be priced at 5.25 by the end of this quarter and at 5.17 in one year, according to Trading Economics global macro models projections and analysts expectations.

Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company. The Company is focused on commercializing generic pharmaceuticals. The Company operates through three segments: International, Branded Products Division (BPD) and Portfolio Products Division (PPD). Its International segment manufactures and sells branded and generic pharmaceutical product globally and the provision of contract development and manufacturing services to third party customers. The BPD segment distributes medically differentiated specialty products in United States. The PPD segment distributes established products (branded and generic) in the United States on a portfolio basis. The Company's products include Doxycycline Capsules, Oxycodone IR Tablets, Erythromycin Capsules and others.